Valeo Financial Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Valeo Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$34.54 - $47.25 $3,523 - $4,819	-102 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$42.51 - $63.78 $4,123 - $6,186	97 Added 1940.0%	102 $5,000
Q4 2020 Feb 11, 2021	BUY	$45.3 - $60.27 $226 - $301	5 New	5 $0
Q3 2020 Oct 28, 2020	SELL	$47.45 - $62.95 $711 - $944	-15 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$59.06 - $72.15 $885 - $1,082	15 New	15 $1,000
Q1 2019 Apr 12, 2019	SELL	$52.92 - $81.17 $3,386 - $5,194	-64 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $31,694 - $39,647	-782 Reduced 92.43%	64 $3,000
Q1 2018 Apr 12, 2018	BUY	$44.08 - $55.05 $37,291 - $46,572	846 New	846 $37,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.